share_log

Baird Reiterates Outperform on Instil Bio, Maintains $180 Price Target

Benzinga ·  Sep 16 22:23  · Ratings

Baird analyst Jack Allen reiterates Instil Bio (NASDAQ:TIL) with a Outperform and maintains $180 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment